Clinical trials testing vaccine-mediated therapy against malignant melanoma have generated disappointing responses. The laboratory of Esteban Celis, MD, PhD, at the GRU Cancer Center proposes that this is due to an insufficient number of antigen...
Researchers and healthcare workers from across the region gathered at GRU on September 18, 2015 for a CME-certified, full-day program, “Tumor Immunology 101: A Navigation Guide for the Growing Field of Cancer Immunotherapy,” organized by GRU Cancer...